Literature DB >> 6892995

Crosslinking of DNA by busulfan. Formation of diguanyl derivatives.

W P Tong, D B Ludlum.   

Abstract

High-pressure liquid chromatography has been used to separate the derivatives of guanosine which are formed when this nucleoside is reacted with busulfan. Derivatives which have been identified by a combination of ultraviolet and mass spectrometry include: 7-(delta-hydroxybutyl)guanosine, 1,4-di(7-guanosyl)butane, and 1-(7-guanyl)-4-(7-guanosinyl)butane. The latter two derivatives can be converted to 1,4-di(7-guanyl)butane by mild acid hydrolysis. Using 1,4-di(7-guanyl)butane as a marker for high-pressure liquid chromatography, we have identified this compound as a product of the reaction between DNA and busulfan. These findings verify the previously unconfirmed report that busulfan is a crosslinking agent for DNA and strengthen the hypothesis that differences in the biological properties of alkylating agents result from differences in their reactions with DNA.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6892995     DOI: 10.1016/0005-2787(80)90145-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Repair of O6-G-alkyl-O6-G interstrand cross-links by human O6-alkylguanine-DNA alkyltransferase.

Authors:  Qingming Fang; Anne M Noronha; Sebastian P Murphy; Christopher J Wilds; Julie L Tubbs; John A Tainer; Goutam Chowdhury; F Peter Guengerich; Anthony E Pegg
Journal:  Biochemistry       Date:  2008-09-20       Impact factor: 3.162

2.  Repair of DNA interstrand crosslinks after busulphan. A possible mode of resistance.

Authors:  P Bedford; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Cross-linking between histones and DNA following treatment with a series of dimethane sulphonate esters.

Authors:  J A Hartley; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Overexpression of glutathione S-transferase A1-1 in ECV 304 cells protects against busulfan mediated G2-arrest and induces tissue factor expression.

Authors:  Christoph A Ritter; Bernhard Sperker; Markus Grube; Dana Dressel; Christiane Kunert-Keil; Heyo K Kroemer
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

5.  Bifunctional cross-linking approaches for mass spectrometry-based investigation of nucleic acids and protein-nucleic acid assemblies.

Authors:  M Scalabrin; S M Dixit; M M Makshood; C E Krzemien; Daniele Fabris
Journal:  Methods       Date:  2018-05-10       Impact factor: 3.608

6.  Comparative studies of DNA cross-linking reactions following methylene dimethanesulphonate and its hydrolytic product, formaldehyde.

Authors:  P M O'Connor; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

7.  Altered gene expression in busulfan-resistant human myeloid leukemia.

Authors:  Benigno C Valdez; David Murray; Latha Ramdas; Marcos de Lima; Roy Jones; Steven Kornblau; Daniel Betancourt; Yang Li; Richard E Champlin; Borje S Andersson
Journal:  Leuk Res       Date:  2008-03-12       Impact factor: 3.156

8.  Busulfan-induced senescence is dependent on ROS production upstream of the MAPK pathway.

Authors:  Virginia Probin; Yong Wang; Daohong Zhou
Journal:  Free Radic Biol Med       Date:  2007-03-31       Impact factor: 7.376

9.  Busulfan therapy of central nervous system xenografts in athymic mice.

Authors:  R H Aaron; G B Elion; O M Colvin; M Graham; S Keir; D D Bigner; H S Friedman
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 10.  Why Great Mitotic Inhibitors Make Poor Cancer Drugs.

Authors:  Victoria C Yan; Hannah E Butterfield; Anton H Poral; Matthew J Yan; Kristine L Yang; Cong-Dat Pham; Florian L Muller
Journal:  Trends Cancer       Date:  2020-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.